
Perspectives on Enquiry & Evidence
Cytel's blog featuring the latest industry insights.

June 13, 2022
The International COVID-19 Data Alliance (ICODA) was formed to address the challenge of generating rapid and rigorous...
Read article

June 6, 2022
The TOGETHER Trial Journey: Interview with Ofir Harari
The award-winning TOGETHER Trial was designed with the vision of ensuring that COVID-19 therapies are both effective...
Read article

May 31, 2022
What it means to be a lead analyst on a Global COVID-19 Trial
The TOGETHER Trial for COVID-19 therapies, designed by clinical trial specialists at Cytel won the Society for Clinical...
Read article

May 17, 2022
Society of Clinical Trials names TOGETHER "Trial of the Year"
Early in the pandemic, it became clear that many of the COVID-19 therapies being tested in wealthier nations, were not...
Read article

April 29, 2022
An Interview with Gabriel Tremblay on his Poster Contributions to ISPOR US 2022
At ISPOR US 2022, Cytel’s HEOR & RWE experts will be contributing to a range of Issue Panels, In-person Podium...
Read article

April 13, 2022
Join Cytel’s HEOR Consultants at ISPOR US 2022
The Life Sciences landscape has seen an impactful digital evolution in the past two years. The pandemic has accelerated...
Read article

December 23, 2021
Year-End Roundup: Your Favorite Blog Posts of 2021
Cytel blogs bring you debate and discussion of the newest trends in statistics and quantitative strategy. In 2021, our...
Read article

October 15, 2021
Applications of Master Protocols in a Global Health Context
Almost 3000 registered trials were performed in COVID-19 and a majority of them have been small and likely...
Read article

May 4, 2021
New Publication on Adaptive Platform Trials
As healthcare systems across the world, continue to grapple with the pressures of COVID-19, Cytel advances yet another...
Read article

April 23, 2021
Bayesian Methods & Vaccines Research: COVID-19
The urgent need to discover and assess the efficacy and safety of COVID-19 vaccine candidates will affect the future...
Read article

March 31, 2021
Wearables and Decentralization
As decentralized clinical trials become more attractive in an era of COVID-19, the role of wearables in clinical...
Read article

February 25, 2021
Use of Wearables in Confirmatory Clinical Trials
The convergence of several distinct trends has made wearables an increasingly attractive option for use in confirmatory...
Read article

February 17, 2021
An Interview with Louis Dron on the Benefits and Future of Cytel’s Trial Tracker
The COVID-19 Pandemic prompted the rapid surge in the generation of clinical data that has been scattered across...
Read article

February 1, 2021
February 2021: Updates from the CYTEL COVID-19 Trial Tracker
Cytel’s COVID-19 Trial Tracker continues to provide real time updates to the status of COVID-19 clinical trials...
Read article

January 22, 2021
The Role of Real World Evidence after COVID19
COVID-19 has transformed the pharmaceutical industry in a manner that few could have predicted only a year ago. One of...
Read article

January 19, 2021
Cytel COVID Panel: Long-term Changes to Clinical Trials Due to the Pandemic
As we enter 2021 with new COVID-19 vaccines and greater optimism about the pipeline of drugs and devices positioned for...
Read article

January 11, 2021
COVID-19 Trial Tracker Updates (January 11)
In April 2020, Cytel launched an open-access global COVID-19 Clinical Trial Tracker to help facilitate greater...
Read article

December 22, 2020
Year-end Roundup: Cytel’s Contributions Towards Health & Education in 2020
At Cytel, we have been diligently working to become an organization deeply committed to uplifting and enriching...
Read article

December 21, 2020
Year-End Roundup: Your Favorite Blog Posts of 2020
2020 has been an unusually difficult year as the global pandemic impacted all of our lives. This year, the Cytel blog...
Read article

December 8, 2020
COVID-19 Trial Tracker Updates (December 8)
The Cytel COVID-19 Trial Tracker brings you an up to the minute, real time dashboard about COVID-19 trials around the...
Read article

December 1, 2020
Mapping the Landscape of COVID-19 Clinical Trials in the US
An extraordinary amount of global research is underway as the COVID-19 pandemic continues to evolve and spread. As...
Read article

November 24, 2020
Cytel and Ingress Health at Virtual ISPOR Europe 2020
Virtual ISPOR 2020, held November 16 to 19, presented new opportunities for scientific interaction amongst HEOR...
Read article

November 12, 2020
Join Cytel and Ingress Health at Virtual ISPOR Europe 2020
Cytel and Ingress Health (now a Cytel company) will be contributing to a range of events at Virtual ISPOR EUROPE 2020,...
Read article

November 10, 2020
Key Design Considerations for Platform Trials
Platform trials are a new type of clinical trials where multiple interventions can be evaluated simultaneously against...
Read article

November 9, 2020
COVID-19 Trial Tracker Updates (November 9)
As the evolving COVID-19 pandemic continues, the Cytel COVID-19 Trial Tracker continues to bring you an up to the...
Read article

October 20, 2020
Interview with Thomas Wilke: Health Economics/World Evidence Studies
In this interview with Thomas Wilke, Principal Scientist at Ingress-Health (a Cytel company), we talk to him about his...
Read article

October 19, 2020
The Uniqueness of COVID-19 Data Challenges; The COVID-19 trial tracker
COVID-19 has created extreme uncertainties -- a dearth of historical information combined with the need for safety,...
Read article

September 30, 2020
A Virtual Event Brought to you by Cytel and Novartis on Innovations
Today, there is a need for advanced quantitative techniques to combine all available information for better decision...
Read article

September 28, 2020
Advantages of platform designs for investigating COVID-19 therapies
Cytel has recently designed and implemented the TOGETHER Trials, funded by the Bill & Melinda Gates Foundation to...
Read article

September 21, 2020
Novel Adaptive Platform Trial for COVID-19 Therapies
Cytel has designed and implemented a novel adaptive platform trial for early stage COVID-19. The severity of the...
Read article

August 11, 2020
Optimizing Information in Trial Design and Implementation
While there is increasing optimism about the discovery of a COVID-19 vaccine, one of the less talked about aspects of...
Read article

August 4, 2020
Estimands and their Implications on Clinical Studies
Last year, Paul Terrill, Associate Principal of Strategic Consulting at Cytel, presented an engaging webinar on the...
Read article

July 11, 2020
COVID-19 Clinical Development Quiz (with Answers)
Last week we challenged you to take a COVID-19 Clinical Development Quiz. Many of you used our Trial Tracker to find...
Read article

July 2, 2020
COVID-19 Clinical Development Quiz
There are currently 1570 registered clinical trials for COVID-19 therapies and vaccines. Approximately 20% are...
Read article

June 29, 2020
The Good Data Submission Doctor: CDISC for COVID-19
From the time the COVID-19 outbreak was declared a pandemic, the number of studies conducted around the world to either...
Read article

June 27, 2020
New Whitepaper: Bayesian Methodologies for COVID-19 Drugs
Expert statisticians at Cytel have spent the past three and a half months designing and deploying dozens of trials for...
Read article

June 18, 2020
Why You Should Construct Primary Endpoints Using Bayesian Methods
One of the revelations of the COVID-19 pandemic is that the flexibility and potential of Bayesian designs goes far...
Read article

June 18, 2020
Optimizing Patient Recruitment: Download Whitepaper
A number of trials recently disrupted by the COVID-19 pandemic are now in the process of re-assessing recruitment...
Read article

June 13, 2020
Weekly Updates from the COVID-19 Trial Tracker (June 12)
The Cytel COVID-19 Trial Tracker continues to bring you an up to the minute, real time dashboard about COVID-19 trials...
Read article

June 9, 2020
Melinda Gates, on COVID-19 and Drug Development in Emerging Economies
Trevor Mundel leads the Bill & Melinda Gates Foundation’s efforts to develop high-impact interventions against the...
Read article

June 4, 2020
COVID-19 Weekly Brief
This weekly snapshot gives you a quick briefing on the state of COVID-19 therapy and vaccines development. As we head...
Read article

May 29, 2020
Trial Tracker: State of COVID-19 Development (May 2020)
At the close of May 2020, we have about 500 new trials globally but trends in trial design and choice of therapies...
Read article

May 28, 2020
Implications for the Future of Drug Development in Emerging Economies
On May 7, Cytel and Certara conducted a virtual panel discussion on new opportunities and implications for the future...
Read article